Safety and efficacy of the Russian COVID-19 vaccine: more information needed - Authors' reply
Lancet
.
2020 Oct 3;396(10256):e54-e55.
doi: 10.1016/S0140-6736(20)31970-X.
Epub 2020 Sep 21.
Authors
Denis Y Logunov
1
,
Inna V Dolzhikova
2
,
Amir I Tukhvatullin
2
,
Dmitry V Shcheblyakov
2
Affiliations
1
N F Gamaleya National Research Centre for Epidemiology and Microbiology, Moscow 123098, Russia. Electronic address: ldenisy@gmail.com.
2
N F Gamaleya National Research Centre for Epidemiology and Microbiology, Moscow 123098, Russia.
PMID:
32971043
PMCID:
PMC7503057
DOI:
10.1016/S0140-6736(20)31970-X
No abstract available
Publication types
Letter
Comment
MeSH terms
Betacoronavirus
COVID-19
COVID-19 Vaccines
Coronavirus Infections* / prevention & control
Humans
Pandemics*
Pneumonia, Viral*
Russia
SARS-CoV-2
Viral Vaccines
Substances
COVID-19 Vaccines
Viral Vaccines